MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Screening risk of falls in Parkinson’s disease population living in underserved areas

    T. Capato, J. Miranda, F. Santos, R. Cury, E. Barbosa (São Paulo, Brazil)

    Objective: To verify the feasibility of the Balance-App to assess the risk of falls in the PD population living in underserved areas. Background: The screening…
  • 2023 International Congress

    Ultra long-term outcome of deep brain stimulation (DBS) compared to botulinum toxin (BoNT) treatment in cervical dystonia (CD)

    IM. Wedding, V. Siewers, IM. Skogseid (Oslo, Norway)

    Objective: To compare residual symptoms and disease-specific quality of life (DS-QoL) in CD patients treated with DBS, or BoNT injections alone, for minimum 3 years.…
  • 2023 International Congress

    Multimodal imaging analysis of autosomal recessive Parkinson’s disease.

    B. Soydas-Turan, G. Yalcin-Cakmakli, E. Yetim, B. Volkan-Salanci, E. Lay-Ergun, K. Karli-Oguz, B. Elibol (Ankara, Turkey)

    Objective: To explore whether autosomal recessive forms of monogenic PD (mPD) might lead to cortical and white matter (WM) abnormalities in addition to dopaminergic denervation.…
  • 2023 International Congress

    Crushing valbenazine capsule contents for potential addition to soft foods or administration via G tube

    M. Hebert, A. Mar, R. Moore, A. Bristow, S. Siegert (San Diego, USA)

    Objective: To evaluate the suitability of mixing crushed contents from valbenazine capsules with soft foods/liquids or adding them to water for delivery through a gastrostomy…
  • 2023 International Congress

    A new synchronization method between inertial signals and local field potentials

    I. D'Ascanio, G. Giannini, L. Baldelli, I. Cani, A. Giannoni, G. Leogrande, G. Lopane, G. Calandra-Buonaura, P. Cortelli, L. Chiari, L. Palmerini (Bologna, Italy)

    Objective: This study aims to define a method to synchronize inertial signals recorded using wearable sensors and local field potentials recorded by the neurostimulator implanted…
  • 2023 International Congress

    The effect of levodopa on the blood activity of calpains in patients with Parkinson’s disease

    Z. Muruzheva, M. Absalyamova, M. Karpenko (Saint-Petersburg, Russian Federation)

    Objective: To evaluate the effect of levodopa on the blood activity of calpains in patients with PD Background: Parkinson's disease (PD) is a chronic progressive…
  • 2023 International Congress

    Botulinum neurotoxin in FXTAS-related tremor: a “successful” case report

    AT. Cimmino, P. Sanginario, AR. Bentivoglio, P. Calabresi, M. Petracca, G. Di Lazzaro (Rome, Italy)

    Objective: We report the case of a man affected by FXTAS, presenting with disabling tremor who experienced a significant and long-lasting benefit from botulinum neurotoxin…
  • 2023 International Congress

    New wearable technology for quantification of freezing of gait in school going adolescent with pediatric movement disorders

    V. Sharma, M. Gautam (Agra, India)

    Objective: To study quantification of  freezing of gait  (FOG) and falls of patients data in school going adolescent with pediatric movement disorders by wearable device…
  • 2023 International Congress

    Understanding caffeine consumption in Huntington’s Disease

    J. Adrissi, S. Brooker, A. Mcbride, D. Larson, E. Gausche, D. Bega (Los Angeles, USA)

    Objective: The purpose of this study is to better understand the amount of caffeine consumption in people with HD and the subjective motivations and consequences…
  • 2023 International Congress

    Spinal cord stimulation for gait in Parkinsons disease in subthreshold settings

    R. Carra, J. Menezes, K. Duarte, M. Teixeira, E. Barbosa, R. Cury (Sao Paulo, Brazil)

    Objective: To assess optimal parameters for tonic spinal cord stimulation (SCS) for Parkinson’s Disease (PD) gait disorders in blinded settings. Background: SCS is a promising…
  • « Previous Page
  • 1
  • …
  • 618
  • 619
  • 620
  • 621
  • 622
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley